Sign up Australia
Proactive Investors - Run By Investors For Investors

Synertec Corporation wins $7.7 million contract to build specialised facility

Synertec delivers specialist engineering solutions across complex and highly regulated industries.
Contracted work in hand is growing strongly for FY19

Synertec Corporation Ltd’s (ASX:SOP) subsidiary has signed a $7.7 million contract to design and build a state of the art bacterial fermentation manufacturing facility in regional Victoria.

The client is one of the largest vaccine manufacturers in the world and the awarded project is part of a regional strategy to develop their facility as a global centre of excellence for Leptospirosis antigen production.

When complete, the expansion works will more than quadruple the facility’s current capacity.

Uniquely positioned to deliver the project

Synertec managing director Michael Carroll said: “We are delighted to be delivering a “state of the art” expansion to the animal vaccine facility.

“This complex and highly regulated project is one which Synertec is uniquely positioned to deliver.

“Furthermore, I am pleased that our contracted work in hand is growing strongly for FY19 on the back of this and other recent announcements.”

READ: Synertec Corporation enters 2018 with strong work book across its engineering business

In January, Synertec was awarded a $1.8 million contract to replace the control and monitoring system of the Melbourne Underground Rail Loop (MURL) fire and life system.

While releasing its half-year result, management highlighted that the company’s prospects for 2018 were enhanced by its strong work in hand.

Contracts awarded recently include two with North Caspian Operating Company N.V. Kazakhstan (NCOC).

This involved the design and supply of instrumentation, electrical and mechanical equipment for a project in the Kashagan field, one of the world’s largest offshore petroleum developments.

View full SOP profile View Profile

Synertec Corporation Ltd Timeline

Related Articles

remote meeting
The acquisition of MeetingZone earlier this year has been called “transformational” by LoopUp bosses
electric vehicle charging
July 04 2018
AMP wants to add 25 sites in Greater London and extend its reach into the North-West around Liverpool and Manchester
Mexican flag
March 26 2018
PLCs in emerging markets no longer have to find someone to promote their company to overseas investors

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use